Attempts To Rein In Drug Reps Should Consider Physician Specialty, Setting
Executive Summary
Guidelines directed at the interaction of sales representatives and physicians should be tailored to medical specialties and settings, according to an analysis of a physician survey published in the April 26 New England Journal of Medicine
You may also be interested in...
Drug Marketing Restrictions Pending In Several State Legislatures
Legislation is pending in several state legislatures that would require pharmaceutical sales representatives to register as lobbyists. Those include legislatures in Louisiana, Connecticut, New Hampshire and Colorado
Sales Reps’ Rx Sampling Could Be Limited Under The “Prescription Project”
The Prescription Project, a new advocacy group formed to limit the influence of gifts and drug samples on prescribing, hopes to persuade academic medical centers to ban the practices by measuring the impact at three institutions that have already imposed limits
Pharma Should Be Excluded From Guideline Development – NEJM Editorial
Standards for the development and adoption of treatment guidelines should be established in light of efforts by industry to manipulate guidelines for commercial purposes, NIH Critical Care Medicine Department senior investigators assert